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Abstract
We apply Generative Adversarial Networks (GANs) to the domain of digital pathology.
Current machine learning research for digital pathology focuses on diagnosis, but we sug-
gest a different approach and advocate that generative models could drive forward the
understanding of morphological characteristics of cancer tissue. In this paper, we develop
a framework which allows GANs to capture key tissue features and uses these character-
istics to give structure to its latent space. To this end, we trained our model on 249K
H&E breast cancer tissue images, extracted from 576 TMA images of patients from the
Netherlands Cancer Institute (NKI) and Vancouver General Hospital (VGH) cohorts.
We show that our model generates high quality images, with a Fre´chet Inception Dis-
tance (FID) of 16.65. We further assess the quality of the images with cancer tissue
characteristics (e.g. count of cancer, lymphocytes, or stromal cells), using quantitative
information to calculate the FID and showing consistent performance of 9.86. Addition-
ally, the latent space of our model shows an interpretable structure and allows semantic
vector operations that translate into tissue feature transformations. Furthermore, ratings
from two expert pathologists found no significant difference between our generated tissue
images from real ones. The code, generated images, and pretrained model are available at
https://github.com/AdalbertoCq/Pathology-GAN
Keywords: Generative Adversarial Networks, Digital Pathology.
1. Introduction
Cancer is a disease with extensive heterogeneity, where malignant cells interact with im-
mune cells, stromal cells, surrounding tissues and blood vessels. Histological images, such as
haematoxylin and eosin (H&E) stained tissue microarrays (TMAs), are a high-throughput
imaging technology used to study such diversity. Despite its growing popularity, compu-
tational analysis of TMAs often lacks analysis of other omics data of the same cohort.
Consequently, cellular behaviours and the tumour microenvironment recorded in TMAs
remain poorly understood.
The motivation for our work is to develop methods that could lead to a better under-
standing of phenotype diversity between/within tumors. We hypothesize that this diversity
could be quite substantial given the highly diverse genomic and transcriptomic landscapes
c© 2020 A.C.Q. , R.M.-S. & K.Y. .
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Figure 1: (a): Images (224×224) from PathologyGAN trained on H&E breast cancer tissue.
(b): Real images, Inception-V1 closest neighbor to the generated above.
observed in large scale molecular profiling of tumors across multiple cancer types (Ciriello
et al., 2013). We argue that representation learning with GAN-based models is the most
promising to achieve our goal for the two following reasons:
1. By being able to generate high fidelity images, a GAN could learn the most relevant
descriptions of tissue phenotype.
2. The continuous latent representation learned by GANs could help us quantify differ-
ences in tissue architectures free from supervised information.
In this paper, we propose to use Generative Adversarial Networks (GANs) to learn
representations of entire tissue architectures and define an interpretable latent space (e.g.
colour, texture, spatial features of cancer and normal cells, and their interaction). To this
end, we present the following contributions:
1. We propose PathologyGANs to generate high fidelity cancer tissue images from an
structured latent space. The model combines BigGAN (Brock et al., 2018), StyleGAN
(Karras et al., 2018) and Relativistic Average Discriminator (Jolicoeur-Martineau,
2018).
2. We assess the quality of the generated images through two different methods: con-
volutional Inception-V1 features and prognostic features of the cancer tissue (such
as counts and densities of different cell types (Beck et al., 2011; Yuan et al., 2012).
Both features are benchmarked with the Fre´chet Inception Distance (FID). The re-
sults show that the model captures pathologically meaningful representations, and
when evaluated by expert pathologists, generated tissue images are not distinct from
real tissue images.
3. We show that our model induces an ordered latent space based on tissue characteris-
tics, this allows to perform linear vector operations that transfer into high level tissue
image changes.
2. Background
GANs (Goodfellow et al., 2014) are generative models that are able to learn high fidelity and
diverse data representations from a target distribution. This is done with a generator, G(z),
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that maps random noise, z ∼ pz(z), to samples that resemble the target data, x ∼ p data (x),
and a discriminator, D(x), whose goal is to distinguish between real and generated samples.
The goal of a GAN is find the equilibrium in the min-max problem:
min
G
max
D
V (D,G) = Ex∼p data (x)[logD(x)] + Ez∼pz(z)[log(1−D(G(z)))]. (1)
Since its introduction, modeling distributions of images has become the mainstream appli-
cation for GANs, firstly proposed by (Radford et al., 2016). State-of-the-art GANs such as
BigGAN (Brock et al., 2018) and StyleGAN (Karras et al., 2018) have recently shown im-
pressive high-resolution images, and proposed solutions like Spectral Normalization GANs
(Miyato et al., 2018), Self-Attention GANs (Zhang et al., 2018), and also BigGAN achieved
high diversity images in data sets like ImageNet (Deng et al., 2009) with 14 million images
and 20 thousand different classes.
At the same time, evaluating these models has been a challenging task. Many different
metrics such as Inception Score (IS) (Salimans et al., 2016), Fre´chet Inception Distance
(FID) (Heusel et al., 2017), Maximum Mean Discrepancy (MMD) (Gretton et al., 2012),
Kernel Inception Distance (KID) (Binkowski et al., 2018), and 1-Nearest Neighbor classifier
(1-NN) (Lopez-Paz and Oquab, 2017) have been proposed to do so, and thorough empirical
studies (Xu et al., 2018; Barratt and Sharma, 2018) have shed some light on the advantages
and disadvantages of each them. However, the selection of a feature space is crucial for
using these metrics.
Currently, machine learning approaches to digital pathology have been focusing on build-
ing classifiers to achieve pathologist-level diagnosis (Esteva et al., 2017; Wei et al., 2019;
Han et al., 2017), and assisting in the decision process through computer-human interaction
(Cai et al., 2019).
Recently, there has been an increasing interest in applying GANs to solve a range of spe-
cific tasks in digital pathology, including staining normalization (Ghazvinian Zanjani et al.,
2018), staining transformation (Rana et al., 2018; Xu et al., 2019), and nuclei segmenta-
tion (Mahmood et al., 2018). Together with deep learning-based classification frameworks
(Esteva et al., 2017; Ardila et al., 2019), these advances offer hope for better disease diag-
nosis than standard pathology (Niazi et al., 2019). Deep learning approaches have a lack of
interpretability, which is a major limiting factor in making a real impact in clinical practice.
For breast cancer, traditional computer vision approaches such as (Beck et al., 2011)
and (Yuan et al., 2012) have identified correlation between morphological features of cells
and patient survival. Based these findings, we propose PathologyGAN as an approach to
learn clinically/pathologically meaningful representations within the cancer tissue images.
3. PathologyGAN
We use BigGAN from (Brock et al., 2018) as a baseline architecture and introduced changes
which empirically improved the Fre´chet Inception Distance (FID) and the structure of the
latent space. We followed the same architecture as BigGAN, employed Spectral Normaliza-
tion in both generator and discriminator, self attention layers, and we also use orthogonal
initialization and regularization as mentioned in the original paper.
We make use of the Relativistic Average Discriminator (Jolicoeur-Martineau, 2018),
where the discriminator’s goal is to estimate the probability of the real data being more
3
Figure 2: High level architecture of PathologyGAN. We include details of each modules
architecture in the Appendix G
realistic than the fake. We take this approach instead of following the Hinge loss (Lim and
Ye, 2017) as the GAN objective. We find that this change makes the model convergence
faster and produce higher quality images. Images using the Hinge loss did not capture the
morphological structure of the tissue (we provide examples of these results in the Appendix
B). The discriminator, and generator loss function are formulated as in Equations 2 and 3,
where P is the distribution of real data, Q is the distribution for the fake data, and C(x) is
the non-transformed discriminator output or critic:
LDis = −Exr∼P
[
log
(
D˜ (xr)
)]
− Exf∼Q
[
log
(
1− D˜ (xf )
)]
, (2)
LGen = −Exf∼Q
[
log
(
D˜ (xf )
)]
− Exr∼P
[
log
(
1− D˜ (xr)
)]
, (3)
D˜ (xr) = sigmoid
(
C (xr)− Exf∼QC (xf )
)
), (4)
D˜ (xf ) = sigmoid (C (xf )− Exr∼PC (xr)) . (5)
Additionally, we introduce two elements from StyleGAN (Karras et al., 2018) with the
purpose of allowing the generator to freely optimize the latent space and find high-level
features of the cancer tissue. First, a mapping network M composed by four dense ResNet
layers (He et al., 2015), placed after the latent vector z ∼ N (0, I), with the purpose of
allowing the generator to find the latent space w ∼M(z) that better disentangles the latent
factors of variation. Secondly, style mixing regularization, where two different latent vectors
z1 and z2 are run into the mapping network and fed at the same time to the generator,
randomly choosing a layer in the generator and providing w1 and w2 to the different halves
of the generator (e.g. on a generator of ten layers and being six the randomly selected
layer, w1 would feed layers one to six and w2 seven to ten). Style mixing regularization
encourages the generator to localize the high level features of the images in the latent space.
We also use adaptive instance normalization (AdaIN) on our models, providing the entire
latent vectors.
We use the Adam optimizer(Kingma and Ba, 2015) with β1 = 0.5 and same learning
rates of 0.0001 for both generator and discriminator, the discriminator takes 5 steps for
4
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Figure 3: CRImage identifies different cell types in our generated images. Cancer cells are
highlighted with a green color, while lymphocytes and stromal cells are high-
lighted in yellow.
each of the generator. Each model was trained on an NVIDIA Titan RTX 24 GB for
approximately 72 hours.
To train our model, we utilize two H&E breast cancer databases from the Netherlands
Cancer Institute (NKI) cohort and the Vancouver General Hospital (VGH) cohort with
248 and 328 patients respectively (Beck et al., 2011). Each of them include TMA images,
along with clinical patient data such as survival time, and estrogen-receptor (ER) status.
The original TMA images all have a resolution of 1128 × 720 pixels, and we split each of
the images into smaller patches of 224 × 224, and allow them to overlap by 50%. We also
perform data augmentation on these images, a rotation of 90◦, and 180◦, and vertical and
horizontal inversion. We filter out images in which the tissue covers less than 70% of the
area. In total this yields a training set of 249K images and a test set of 62K.
4. Results
4.1. Image quality analysis
We evaluate our models using the Fre´chet Inception Distance (FID), we take the usual pro-
cedure of using convolutional features of a Inception-V1 network. As additional assessment,
we use cellular information of the tissue image to calculate the FID score, the motivation
behind this approach is to ensure that our models capture meaningful and faithful repre-
sentations of the tissue.
The CRImage tool (Yuan et al., 2012) uses an SVM classifier to provide quantitative
information about tumor cellular characteristics in cancer tissue. This approach allows us
to gather pathological information in the images, namely the number of cancer cells, the
number of other types of cells (such as stromal or lymphocytes), and the ratio of tumorous
cells per area. We use this information as features to calculate the FID metric. Figure 3
Model Inception FID CRImage FID
PathologyGAN 16.65±2.5 9.86±0.4
Table 1: Evaluation of PathologyGANs. Mean and standard deviations are computed over
three different random initializations. The low FID scores in both feature space
suggest consistent and accurate representations.
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displays an example of how the tool captures the different cells in the generated images,
such as cancer cells, stromal cells, and lymphocytes.
We evaluate our model with the FID score, generating 5000 fake images, and randomly
selecting 5000 real images. We also use both approaches for feature space selection, using
CRImage cell classifier and the convolutional features of an Inception-V1.
Table 1 shows that our model is able to achieve a accurate characterization of the cancer
tissue. Using the Inception feature space, FID shows a stable representation for all models
with values similar to ImageNet models of BigGAN (Brock et al., 2018) and SAGAN (Zhang
et al., 2018)), with FIDs of 7.4 and 18.65 respectively or StyleGAN (Karras et al., 2018)
trained on FFHQ with FID of 4.40. Using the CRImage cellular information as feature
space, FID shows again close representations to real tissue.
4.2. Analysis of latent representations
In this section we focus on the PathologyGAN’s latent space, exploring the impact of
introducing a mapping network in the generator and using style mixing regularization. We
include a complete comparison on using these two features in the Appendix C. Here we will
provide examples of its impact on linear interpolations and vector operations on the latent
space z, as well as visualizations on the latent space w.
In Figure 4 we capture how the latent space w has a structure that shows direct rela-
tionship with the number of cancer cells in the tissue. We generated 10, 000 images and
use CRImage to extract the count of cancer cells in the tissue, using this information we
created 8 different classes that account for counts of cancer cells in the tissue image, and
consecutively we label each image with the corresponding class. Along with each tissue
image we have the corresponding latent vector w, we used UMAP (McInnes et al., 2018) to
project it to two dimensional space.
In each of the sub-figures (a-h) in Figure 4, we provide a density plot of latent vectors
w for each class, (a) corresponds to generated images with the lowest count of cancer cells
in the tissue and (h) to images with the largest, as we increase the number of cancer cells
in the image, the density of the latent vectors w moves from quadrant IV to quadrant II
in the UMAP representation.
We also found that linear interpolations between two latent vectors z have better feature
transformations when the mapping network and style mixing regularization are introduced.
Figure 5 shows linear interpolations in latent space z between images with malignant tissue
and benign tissue. (a) corresponds to a model with a mapping network and style mixing
regularization and (b) to a model without those features, we can see that transitions on (a)
include an increasing population of cancer cells rather than the fading effect observed in
images of (b). This result indicates that (a) better translates interpolations in the latent
space, as real cells do not fade away.
Finally, we performed linear vector operations in z, that translated into semantic image
features transformations. In Figure 6 we provide examples of three vector operations that
result into feature alterations in the images. This evidence shows further support on the
relation between a structured latent space and tissue characteristics.
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Figure 4: Density plots of samples on the UMAP reduced representation of the latent space
w. Each subfigure (a-h) belongs to samples of only one class, where each class
represents a range of counts of cancer cells in the tissue image. (a) accounts for
images with the lowest number of cancer cells and (h) corresponds to images with
the largest count, subfigures from (a) to (h) belong to increasing number of cancer
cells. This figure shows how increasing the number of cancer cells in the tissue
image corresponds to moving the latent vectors from regions of quadrant IV to
quadrant II.
Figure 5: Linear interpolation in the latent space z from a benign (less cancer cells, left
end) to a malignant tissue (more cancer cells, right end). (a) PathologyGAN
model interpolations with a mapping network and style mixing regularization.
(b) PathologyGAN model interpolations without a mapping network and style
mixing regularization. (a) includes an increasing population of cancer cells rather
than a fading effect from model (b), this shows that model (a) better translates
high level features of the images from the latent space vectors.
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Figure 6: Linear vector operations on the latent space z translate into image feature
transformations. We gather latent vectors that generate images with different
high level features and perform linear operations on the vectors before we feed
the generator, resulting into semantic translations of the characteristics of the
images. We perform the following operations (a) Benign tissue and lymphocytes
- benign tissue + tumorous tissue = cancer cells and lymphocytes, (b) Benign
tissue with patches of cancer cells - tumorous = benign tissue, and (c) Tumorous
tissue with lymphocytes - benign tissue with lymphocytes + benign tissue =
tumorous or necrotic tissue.
4.3. Pathologists’ results
To demonstrate that the generated images can sustain the scrutiny of clinical examination,
we asked two expert pathologists to take two different tests, setup as follows:
• Test I: 25 Sets of 8 images - Pathologists were asked to find the only fake image in
each set.
• Test II: 50 Individual images - Pathologists were asked to rate all individual images
from 1 to 5, where 5 meant the image appeared the most real.
In total, each of the pathologists classified 50 individual images and 25 sets of 8 images.
We chose fake images in two ways, with half of them hand-selected and the other half with
fake images that had the smallest Euclidean distance to real images in the convolutional
feature space (Inception-V1). All the real images are randomly selected between the three
closest neighbors of the fake images.
On Test I, pathologist 1 and 2 were able to find only 2 fake out of the 25 sets, and 3
out of the 25, respectively. This is indicative of the images’ quality because we argue that
pathologists should be less challenged to find fake images amongst real ones, since having
other references to compare with facilitates the task. Figure 7 shows Test II in terms of false
positive vs true positive, and we can see that pathologist classification is close to random.
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Figure 7: ROC curve of Pathologists’ classification for images in Test II. The near random
classification performance from both expert pathologists suggests that generated
tissue images do not present artifacts that give away the tissue as generated.
The pathologists mentioned that the usual procedure is to work with larger images with
bigger resolution, but that the generated fake images were of a quality, that at the 224×224
size used in this work, they were not able to differentiate between real and fake tissue.
5. Conclusion
We presented a new approach to the use of machine learning in digital pathology, using
GANs to learn cancer tissue representations. We assessed the quality of the generated
images through the FID metric, using the convolutional features of a Inception-V1 network
and quantitative cellular information of the tissue, both showed consistent state-of-the-
art values of 16.65 and 9.86. We showed that our model allows high level interpretation
of its latent space, even performing linear operations that translate into feature tissue
transformations. Finally, we demonstrate that the quality of the generated images do not
allow pathologists to reliably find differences between real and generated images.
As future work, this model could be extended to achieve higher resolutions of 1024x1024
as TMAs, further experimentation with pathologists and non-experts classification on gen-
erated tissue, as well as studies of borderline cases (e.g. atypia) between generated images
and pathologists interpretations.
We are most interested in extending our model so it can provide novel understanding
of the complex tumor microenvironment recorded in the WSIs, and this is where we think
the tissue representation learning properties of our model is key. Being able to encode
real tissue patches from WSIs and introducing an encoder into the model that allows us to
project real tissue onto the GANs latent space.
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Appendix A. Code
We provide the code at this location.
Appendix B. Hinge vs Relativistic Average Discriminator
In this section we show corresponding generated images and loss function plots for Rela-
tivistic Average Discriminator model and Hinge Loss model.
Figure 8: Left grid images correspond to Relativistic Average Discriminator model vs right
grid images from the Hinge loss model. We can see that the Relativistic Average
model is able to reproduce cancer tissue characteristics compared to Hinge loss,
which does not.
Figure 9: (a) Generator and Discriminator loss functions of the Relativistic Average Dis-
criminator model, (b) Generator and Discriminator loss functions from the Hinge
loss model. Here we capture the corresponding loss functions to the images in
Figure 8, both of them converge but only Relativistic Average Discriminator
produces meaningful images.
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Appendix C. Mapping Network and Style Mixing Regularization
Comparison
To measure the impact of introducing a mapping network and using style mixing regular-
ization during training, we provide different figures of the latent space w for two Patholo-
gyGANs, one using these features and another one without them.
Figures 10, 11, and 12 capture the clear difference in the latent space ordering with
respect to the counts of cancer cells in the tissue image. Without a mapping network and
style mixing regularization the latent space w shows a random placement of the vectors
subject to the tissue images, when these two elements are introduced moving the selected
vector int the latent space from quadrant IV to quadrant II results into increasing the
number of cancer cells in the tissue.
Figure 10: Latent space w ∈ R200 visualization of 10, 000 vector samples on a UMAP re-
duced space of 2 dimensions, each vector’s generated image was label using
CRImage and annotated with the respective class subject to the count of cancer
cells in the image. Class 0 accounts for images with the lowest count cancer
cells, on the other extreme Class 8 accounts for images with the larger count.
(a) corresponds to latent space of a PathologyGAN with a mapping network
and style mixing regularization, and (b) to a PathologyGAN without these two
features. We show that in model (b) vector samples are randomly placed in
the latent space w, where in (a) vector samples increasingly concentrate in the
quadrant II as we increase the number of cancer cells in the tissue images.
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Figure 11: Comparison of the latent space w for two different PathologyGAN models, (a-
h) include a mapping network and style mixing regularization, and (i-p) do not
include them. Each sub-figure shows datapoints only related to one of the classes,
and each class is subject to the count of cancer cells in the tissue image, (a) and
(i) [class 0] are associated to images with the lowest number of cancer cells, (h)
and (p) [class 8] with the largest. In the model (a-h) images with increasing
number of cancer cells correspond to proportionally moving to quadrant II in
the 2 dimensional space , where (i-p) are randomly placed.
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Figure 12: Comparison of the latent space w for two different PathologyGAN models, (a-h)
include a mapping network and style mixing regularization, and (i-p) do not
include them. Each sub-figure shows the density of datapoints only related to
one of the classes, and each class is subject to the count of cancer cells in the
tissue image, (a) and (i) [class 0] are associated to images with the lowest number
of cancer cells, (h) and (p) [class] with the largest. In the model (a-h) images
with increasing number of cancer cells correspond to proportionally moving to
quadrant II in the 2 dimensional space , where (i-p) are randomly placed.
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Appendix D. Vector Operation Samples
Figure 13: Samples of vector operations with different images, all operations correspond to:
Benign tissue and lymphocytes- benign tissue + tumorous tissue = cancer cells
and lymphocytes.
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Figure 14: Samples of vector operations with different images, all operations correspond to:
Benign tissue with patches of cancer cells - tumorous = benign tissue.
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Figure 15: Samples of vector operations with different images, all operations correspond to:
Tumorous tissue with lymphocytes - benign tissue with lymphocytes + benign
tissue = tumorous or necrotic tissue.
Appendix E. PathologyGAN at 448x448
We include in this section experimental results of a 448× 448 image resolution model. We
trained this model for 90 epochs over approximately five days, using four NVIDIA Titan
RTX 24 GB.
Over one model the results of Inception FID and CRImage FID were 29.53 and 203
respectively. We found that CRImage FID is highly sensitive to changes in the images since
it looks for morphological shapes of cancer cells, lymphocytes, and stroma in the tissue,
at this resolution the generated tissue images don’t hold the same high quality as in the
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224×224 case. As we capture in the Conclusion section, this is an opportunity to improve
the detail in the generated image at high resolutions.
Figure 16 show three examples of comparisons between (a) PathologyGAN images and
(b) real images. Additionally, the representation learning properties are still preserved in
the latent space. Figure 17 captures the density of cancer cells in the 448×448 tissue images
as previously presented for the 224× 224 case in Appendix C.
Figure 16: (a): Images (448 × 448) from PathologyGAN trained on H&E breast cancer
tissue. (b): Real images.
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Figure 17: Scatter and density plots of 448× 448 samples on the UMAP reduced represen-
tation of the latent space w. Each subfigure (a-h) belongs to samples of only one
class, where each class represents a range of counts of cancer cells in the tissue
image. (a) accounts for images with the lowest number of cancer cells and (h)
corresponds to images with the largest count, subfigures from (a) to (h) belong
to increasing number of cancer cells.
Appendix F. GAN evaluation metrics for digital pathology
In this section, we investigate how relevant GAN evaluation metrics perform on distinguish-
ing differences in cancer tissue distributions. We center our attention on metrics that are
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model agnostic and work with a set of generated images. We focus on Fre´chet Inception
distance (FID), Kernel Inception Distance (KID), and 1-Nearest Neighbor classifier (1-NN)
as common metrics to evaluate GANs. We do not include Inception Score and Mode Score
because they do not compare to real data directly, they require a classification network on
survival times and estrogen-receptor (ER), and they have also showed lower performance
when evaluating GANs (Barratt and Sharma, 2018; Xu et al., 2018).
(Xu et al., 2018) reported that the choice of feature space is critical for evaluation
metrics, so we follow these results by using the ’pool 3’ layer from an ImageNet trained
Inception-V1 as a convolutional feature space.
We set up two experiments to test how the evaluation metrics capture:
• Artificial contamination from different staining markers and cancer types.
• Consistency when two sample distributions of the same database are compared.
F.1. Detecting changes in markers and cancer tissue features
We used multiple cancer types and markers to account for alterations of color and shapes
in the tissue. Markers highlight parts of the tissue with different colors, and cancer types
have distinct tissues structures. Examples of these changes are displayed in Figure 18.
We constructed one reference image set with 5000 H&E breast cancer images from our
data sets of NKI and VGH, and compared it against another set of 5000 H&E breast
cancer images contaminated with other markers and cancer types. We used three types
of marker-cancer combinations for contamination, all from the Stanford TMA Database
(Marinelli et al., 2008): H&E - Bladder cancer, Cathepsin-L - Breast cancer, and CD137 -
Lymph/Colon/Liver cancer.
Figure 18: Different cancer types and markers. (a) H&E Breast cancer, (b) H&E Bladder
cancer, (c) Capthepsin-L Breast cancer, and (d) CD137 Bone marrow cancer.
We can see different coloring per marker, and tissue architecture per cancer type.
Each set of images was constructed by randomly sampling from the respective marker-
cancer type data set, which is done to minimize the overlap between the clean and contam-
inated sets.
Figure 19 shows how (a) FID, (b) KID, (c) 1-NN behave when the reference H&E breast
cancer set is measured against multiple percentage of contaminated H&E breast cancer sets.
Marker types have a large impact due to color change and all metrics capture this except for
1-NN. Cathepsin-L highlights parts of the tissue with brown colors and CD137 has similar
color to necrotic tissue on H&E breast cancer, but still far from the characteristic pink color
of H&E. Accordingly, H&E-Bladder has a better score in all metrics due to the color stain,
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again expect for 1-NN. Cancer tissue type differences are captured by all the metrics, which
shows a marker predominance, but we can see that on the H&E marker the differences
between breast and bladder types are still captured.
In this experiment, we find that FID and KID have a gradual response distinguishing
between markers and cancer tissue types, however 1-NN is not able to give a measure that
clearly defines these changes.
Figure 19: Distinguishing a set H&E Breast cancer images against different contamination
of markers and cancer types. For a metric to be optimnal, the value should
decreas along with the contamination. (a) corresponds to FID, (b) KID, (c)
1-NN. FID and KID gradually define changes in marker and tissue type, 1-NN
does not provide a clear measure of the changes.
F.2. Reliability on evaluation metrics
Another evaluation we performed was to study which metrics are consistent when two
independent sample distributions with the same contamination percentage are compared.
To construct this test, for each contamination percentage, we create two independent sample
sets of 5000 images and compare them against each other. Again, we constructed these
image sets by randomly selecting images for each of the marker-cancer databases. We do
this to ensure there are no overlapping images between the distributions.
In Figure 20 we show that (a) FID has a stable performance, compared to (b) KID,
and especially (c) 1-NN. The metrics should show a close to zero distance for each of the
contamination rates since we are comparing two sample-distributions from the same data
set. This shows that only FID has a close to zero constant behavior across different data
sets when comparing the same tissue image distributions.
Based on these two experiments, we argue that 1-NN does not clearly represent changes
in the cancer types and marker, and both KID and 1-NN do not give a constant reliable
measure across different markers and cancer types. Therefore we focused on FID as the
most promising evaluation metrics.
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Figure 20: Consistency of metrics when two independent sets of images with the same
contamination are compared. Consistent metrics should be close to zero for
each of the contamination rates. (a) FID, (b) KID, and (c) 1-NN, we can see
that FID is the metric that shows a close to zero constant measure.
Appendix G. Model Architecture
Mapping Network M : z → w
z ∈∼ R200 ∼ N (0, I)
ResNet Dense Layer and ReLU, 200→ 200
ResNet Dense Layer and ReLU, 200→ 200
ResNet Dense Layer and ReLU, 200→ 200
ResNet Dense Layer and ReLU, 200→ 200
Dense Layer, 200→ 200
Table 2: Mapping Network Architecture details of PathologyGAN model.
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Generator Network G : w → x
Dense Layer, adaptive instance normalization (AdaIN), and leakyReLU
200→ 1024
Dense Layer, AdaIN, and leakyReLU
1024→ 12544
Reshape 7× 7× 256
ResNet Conv2D Layer, 3x3, stride 1, pad same, AdaIN, and leakyReLU 0.2
7× 7× 256→ 7× 7× 256
ConvTranspose2D Layer, 2x2, stride 2, pad upscale, AdaIN, and leakyReLU 0.2
7× 7× 256→ 14× 14× 512
ResNet Conv2D Layer, 3x3, stride 1, pad same, AdaIN, and leakyReLU 0.2
14× 14× 512→ 14× 14× 512
ConvTranspose2D Layer, 2x2, stride 2, pad upscale, AdaIN, and leakyReLU 0.2
14× 14× 512→ 28× 28× 256
ResNet Conv2D Layer, 3x3, stride 1, pad same, AdaIN, and leakyReLU 0.2
28× 28× 256→ 28× 28× 256
Attention Layer at 28× 28× 256
ConvTranspose2D Layer, 2x2, stride 2, pad upscale, AdaIN, and leakyReLU 0.2
28× 28× 256→ 56× 56× 128
ResNet Conv2D Layer, 3x3, stride 1, pad same, AdaIN, and leakyReLU 0.2
56× 56× 128→ 56× 56× 128
ConvTranspose2D Layer, 2x2, stride 2, pad upscale, AdaIN, and leakyReLU 0.2
56× 56× 128→ 112× 112× 64
ResNet Conv2D Layer, 3x3, stride 1, pad same, AdaIN, and leakyReLU 0.2
112× 112× 64→ 112× 112× 64
ConvTranspose2D Layer, 2x2, stride 2, pad upscale, AdaIN, and leakyReLU 0.2
112× 112× 64→ 224× 224× 32
Conv2D Layer, 3x3, stride 1, pad same, 32→ 3
224× 224× 32→ 224× 224× 3
Sigmoid
Table 3: Generator Network Architecture details of PathologyGAN model.
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Discriminator Network C : x→ d
x ∈ R224×224×3
ResNet Conv2D Layer, 3x3, stride 1, pad same, and leakyReLU 0.2
224× 224× 3→ 224× 224× 3
Conv2D Layer, 2x2, stride 2, pad downscale, and leakyReLU 0.2
224× 224× 3→ 122× 122× 32
ResNet Conv2D Layer, 3x3, stride 1, pad same, and leakyReLU 0.2
122× 122× 32→ 122× 122× 32
Conv2D Layer, 2x2, stride 2, pad downscale, and leakyReLU 0.2
122× 122× 32→ 56× 56× 64
ResNet Conv2D Layer, 3x3, stride 1, pad same, and leakyReLU 0.2
56× 56× 64→ 56× 56× 64
Conv2D Layer, 2x2, stride 2, pad downscale, and leakyReLU 0.2
56× 56× 64→ 28× 28× 128
ResNet Conv2D Layer, 3x3, stride 1, pad same, and leakyReLU 0.2
28× 28× 128→ 28× 28× 128
Attention Layer at 28× 28× 128
Conv2D Layer, 2x2, stride 2, pad downscale, and leakyReLU 0.2
28× 28× 128→ 14× 14× 256
ResNet Conv2D Layer, 3x3, stride 1, pad same, and leakyReLU 0.2
14× 14× 256→ 14× 14× 256
Conv2D Layer, 2x2, stride 2, pad downscale, and leakyReLU 0.2
14× 14× 256→ 7× 7× 512
Flatten 7× 7× 512→ 25088
Dense Layer and leakyReLU, 25088→ 1024
Dense Layer and leakyReLU, 1024→ 1
Table 4: Discriminator Network Architecture details of PathologyGAN model.
Appendix H. Pathologists Tests
We provide in here examples of the test taken by the pathologists:
• Test I: Sets of 8 images - Pathologists were asked to find the only fake image in each
set.
• Test: II: 10 Individual images - Pathologists were asked to rate all individual images
from 1 to 5, where 5 meant the image appeared the most real.
Additionally we include the complete tests and solutions.
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Figure 21: Example of Test I.
Figure 22: Two examples of Test II.
Appendix I. Images
We show here two types of figures:
• Hand-selected fake images with real Inception-V1 closest neighbors.
• Fake images with the smallest distance to real Inception-V1 closest neighbors.
Figure 23: Hand-selected fake images: for each row, the first image is a generated one, the
remaining seven images are close Inception-V1 neighbors of the fake image.
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Figure 24: Minimum distance fake images:For each row, the first image is a generated one,
the remaining seven images are close Inception-V1 neighbors of the fake image.
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